Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MEND-CABG II: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG Surgery

NCT00402506 is registered in ClinicalTrials.gov with Medicure as lead sponsor.

NCT NCT00402506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00402506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MEND-CABG II: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG Surgery
Lead sponsor
Medicure
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2006
Completion date
September 30, 2007
Enrollment
3,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass graft surgery, myocardial ischemia, reperfusion injury